Identified three methylation sites relevant to distinguishing CAC from sporadic CRC and defined methylation limit values. Combination of MICAL3, MAD1L1, and METTL22 methylation sites allowed for correct assignment to CAC or sporadic CRC in 94.5% of cases. This evidence concerns the gene METTL22 and colorectal carcinoma.